# Catalent Germany Eberbach GmbH – FDA Inspection, Feb 2, 2024

Source: https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/5a4da443-351c-4f3b-8bd1-0c11e78876e7
Source feed: FDA_Inspections

> FDA inspection 1255823 of Catalent Germany Eberbach GmbH, February 02, 2024. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255823
- Company Name: Catalent Germany Eberbach GmbH
- Inspection Date: 2024-02-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1106613 - 2019-09-06](https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/d64a79a5-768c-4018-93dc-9cd292aeaaa9)
- [FDA Inspection 1048712 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/f27409b9-09c8-4e11-88d6-eee186cf0664)
- FDA Inspection 989834 - 2016-03-18
- FDA Inspection 850147 - 2013-09-12
- FDA Inspection 818378 - 2013-02-08

Company: https://www.keypedia.com/companies/catalent-germany-eberbach-gmbh/fcf97f2a-c54b-4105-afc0-11a0c999d8a5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c